Major Shareholding Notification • Dec 5, 2017
Major Shareholding Notification
Open in ViewerOpens in native device viewer
Flagging
Oslo, 4 December 2017
Following today's purchase of 160.000 shares in Gentian Diagnostics, Vatne Equity AS owns 760.000 shares in the Company, corresponding to 5,43% of the outstanding shares.
In addition, Lioness AS, a sister company of Vatne Equity AS, has today purchased 100.000 shares in Gentian Diagnostic ASA, corresponding to 0,71% of the outstanding shares.
Vatne Equity AS and Lioness AS together own 860.000 shares in Gentian Diagnostics, corresponding to 6,14% of the outstanding shares.
For further information, please contact:
Henrik Krefting, CEO
(+47) 916 12 279 / Email: [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.